Essayer OR - Gratuit
There's crushing news for people who want to live long
Mint Mumbai
|April 21, 2025
A wonder drug that a wealthy longevity seeker was testing on himself may have turned out to be a dud
A few days ago, Bryan Johnson, a centi-millionaire who has spent millions on reversing ageing—especially his own—posted some bad news for humanity on his YouTube channel. Rapamycin, which for a long time has been the most promising molecule in our quest to prolong youth, was not making him younger; instead, it was "accelerating" his ageing.
Johnson, who is 47 and looks 46, conducts various experiments on himself in his effort to live like a young man for a very long time. I am counting on him. His food consumption is so calibrated that he knows the number of calories he has gulped. He does not eat after 11 am, unless he has to meet people socially and must eat at ungodly hours like 7 pm just to shut them up. He sleeps around 8:30 pm, alone. I know he has high standards for himself because he recently visited Delhi, probably out of ignorance, and refused to breathe the air for too long. Among the most important things he was performing on himself was taking small quantities of rapamycin, a drug that is chiefly used to prevent the body's rejection of organ transplants. It does not have approval as an anti-ageing drug, though it is widely believed to have potential for that. The compound had extended the lifespan of mice and worms beyond ambiguity, and of other animals, too. Johnson was its most famous human test subject.
Cette histoire est tirée de l'édition April 21, 2025 de Mint Mumbai.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Mint Mumbai
Mint Mumbai
Europe bets on $25 bn space budget amid defence hike
Europe’s equivalent of NASA is seeking €22 billion ($25.
1 min
November 27, 2025
Mint Mumbai
China’s ‘McNuggetization’: It’s beneficial for the environment
A wide-scope dietary shift in China is doing the planet a good turn
3 mins
November 27, 2025
Mint Mumbai
Flexi-cap funds in focus as smids falter
A silent pivot
3 mins
November 27, 2025
Mint Mumbai
Labour codes: Focus on empathy and not just efficiency
The consolidation of 29 archaic labour laws into four comprehensive new codes—on wages, social security, industrial relations and occupational safety—is among the most significant structural reforms undertaken by India in the post-liberalization era.
3 mins
November 27, 2025
Mint Mumbai
These firms will sell shovels during semaglutide gold rush
Weight-loss drug semaglutide, also used to treat type-2 diabetes, will face its next big turning point in early 2026, when patents held by Novo Nordisk expire in India.
2 mins
November 27, 2025
Mint Mumbai
HC to hear Apple's plea on fine in Dec
Apple is challenging the new penalty math formula in India's competition law.
1 min
November 27, 2025
Mint Mumbai
Climate crisis: Innovation works, compression doesn't
After weeks of hot air, the UN’s CoP summit limped to an end in Brazil's Amazonian hub of Belém over the weekend, with a ‘deal’ that delivers nothing measurable for the climate, while wasting political capital and much effort on pledges.
3 mins
November 27, 2025
Mint Mumbai
MO Alternates launches its maiden private credit fund
The %3,000 crore fund has drawn capital from family offices, ultra-HNIs and institutions
3 mins
November 27, 2025
Mint Mumbai
Kharif grain production likely to rise to 173 mt
India's kharif foodgrain output is expected to rise to 173.
1 min
November 27, 2025
Mint Mumbai
IL&FS group repays ₹48,463 cr loan
Debt-ridden IL&FS group has repaid ₹48,463 crore to its creditors as of September 2025, out of the total ₹61,000 crore debt resolution target, as per the latest status report filed before insolvency appellate tribunal NCLAT.
1 min
November 27, 2025
Listen
Translate
Change font size

